SK Biopharmaceuticals Enters AI-Powered Drug Discovery Collaboration With Insilico Medicine for Up to $2.5 Billion
June 23, 2026
June 23, 2026
BOSTON, Massachusetts, June 23 -- Ropes and Gray, a law firm, issued the following news:
* * *
SK Biopharmaceuticals Enters AI-Powered Drug Discovery Collaboration with Insilico Medicine for up to $2.5 Billion
Ropes & Gray advised South Korea-based SK Biopharmaceuticals in a research and development collaboration with Insilico Medicine to discover AI-enabled drug candidates in neuroimmune disorders of the central nervous system in a deal worth up to $2. . . .
* * *
SK Biopharmaceuticals Enters AI-Powered Drug Discovery Collaboration with Insilico Medicine for up to $2.5 Billion
Ropes & Gray advised South Korea-based SK Biopharmaceuticals in a research and development collaboration with Insilico Medicine to discover AI-enabled drug candidates in neuroimmune disorders of the central nervous system in a deal worth up to $2. . . .